Product Information
HALOPERIDOL 5 MG TABLET is a generic product labeled by Burel Pharmaceuticals, LLC, priced at $0.1801 per EA under NDC 35573044102. Its NADAC has been published 229 times since Jan 5, 2022.
Strength
5 mg/1
Manufacturer
Burel Pharmaceuticals, LLCNDC
35573044102
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
HALOPERIDOLApproval Type
Generic (ANDA)
FDA Application
ANDA071131On Market Since
5/31/2021
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL 5 MG TABLET has been published 229 times since Jan 5, 2022, and over the history we have for it it has declined 62.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1801 per EA |
|---|---|
| All-time high | $0.4746 (Jan 12, 2022) |
| All-time low | $0.1776 (Apr 22, 2026) |
| 52-week high | $0.1980 |
| 52-week low | $0.1776 |
| Median price | $0.3324 |
| Average price | $0.3160 |
| Largest weekly change | +27.9% (Aug 21, 2024) |
| Weeks tracked | 229 |
| Tracking since | Jan 5, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
-1.6%
1Y
-8.5%
3Y
-45.8%
5Y
N/A
All
-62.0%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the HALOPERIDOL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Burel Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HALOPERIDOL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL 5 MG TABLET, manufactured by Burel Pharmaceuticals, LLC, is $0.1801 per EA (NDC 35573044102), effective May 20, 2026.
How has the price of HALOPERIDOL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL 5 MG TABLET has declined 62.0%. It has been tracked across 229 weekly CMS publications since Jan 5, 2022.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL 5 MG TABLET?
Since Jan 5, 2022, the NADAC for HALOPERIDOL 5 MG TABLET has ranged from a low of $0.1776 (Apr 22, 2026) to a high of $0.4746 (Jan 12, 2022), with a median of $0.3324 per EA.
Are there cheaper alternatives to HALOPERIDOL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of HALOPERIDOL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HALOPERIDOL 5 MG TABLET?
HALOPERIDOL 5 MG TABLET (NDC 35573044102) is labeled by Burel Pharmaceuticals, LLC, and CMS classifies it as a generic product.